Current trends in the promising immune checkpoint inhibition and radiotherapy combination for locally advanced and metastatic urothelial carcinoma-Reference-Cited by-同舟云学术

Current trends in the promising immune checkpoint inhibition and radiotherapy combination for locally advanced and metastatic urothelial carcinoma

Published:2023-10-24 Issue:12 Volume:28 Page:1573-1584
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Sano Takeshi^ORCID,Saito Ryoichi,Aizawa Rihito,Watanabe Tsubasa,Murakami Kaoru,Kita Yuki,Masui Kimihiko,Goto Takayuki,Mizowaki Takashi,Kobayashi Takashi^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s10147-023-02421-y.pdf

Reference93 articles.

1. Moschini M, D’Andrea D, Korn S et al (2017) Characteristics and clinical significance of histological variants of bladder cancer. Nat Rev Urol 14(11):651–668. https://doi.org/10.1038/nrurol.2017.125

2. Witjes JA, Bruins HM, Cathomas R et al (2021) European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol 79(1):82–104. https://doi.org/10.1016/j.eururo.2020.03.055

3. Flaig TW, Spiess PE, Agarwal N et al (2020) Bladder cancer, Version 3.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 18(3):329–354. https://doi.org/10.6004/jnccn.2020.0011

4. Powles T, Park SH, Voog E et al (2020) Avelumab maintenance therapy for advanced or metastatic urothelial carcinoma. N Engl J Med 383(13):1218–1230. https://doi.org/10.1056/NEJMoa2002788

5. Bellmunt J, de Wit R, Vaughn DJ et al (2017) Pembrolizumab as second-line therapy for advanced urothelial carcinoma. N Engl J Med 376(11):1015–1026. https://doi.org/10.1056/NEJMoa1613683

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Radiotherapy as a Promising Alternative for Managing Advanced Upper Tract Urothelial Carcinoma: Rescuing Chemotherapy-Intolerant Patients;Clinical Genitourinary Cancer;2024-12

2. Outcomes of radical radiotherapy for the treatment of localized renal pelvic and ureteral carcinoma intolerant to surgery: a real-world study;Clinical Genitourinary Cancer;2024-09